Zscaler (ZS) Q3 2026 Earnings: Key Takeaways and Market Reaction
Zscaler (ZS) announced its Q3 2026 earnings on May 26, revealing strong results but mixed guidance that led to a significant market reaction...
AppLovin:: Delivered top- and bottom-line beats for Q4, with Q1 guidance ahead of estimates. Q4 revenue was $1.66 billion (vs. $1.61 billion est.) and adjusted EBITDA was $1.4 billion (vs. $1.33 billion est.). Q1 sales are expected to range from $1.75 billion to $1.78 billion with adjusted EBITDA of $1.47 billion to $1.5 billion.
Cisco:: Beat expectations for Q2 sales and EPS. Non-GAAP earnings per share were $1.04 (vs. $1.02 expected) and sales were $15.35 billion (vs. $15.11 billion expected). AI infrastructure orders from hyperscalers reached $2.1 billion. Fiscal year 2026 sales guidance is $61.2 billion to $61.7 billion.
McDonald’s:: Reported Q4 earnings and sales that beat Wall Street estimates, driven by “value leadership.” Adjusted earnings per share were $3.12 (vs. $3.05 expected) and revenue was $7 billion (vs. $6.8 billion expected). Global comparable-store sales growth was 5.7% (vs. 3.9% expected).
Gilead:: Rose after earnings beat driven by HIV drug sales. Adjusted earnings per share were $1.86 (vs. $1.81 expected) and revenue was $7.9 billion (vs. $7.6 billion expected). The company expects adjusted earnings per share of $8.45 to $8.85 for the full year 2026 and revenue of $29.6 billion to $30 billion.
Micron:: Jumped as the CFO announced the company has started HBM4 shipments ahead of schedule. High-volume production on HBM4 has commenced, with customer shipments ramping successfully in Q1. Supply-demand tightness for high-bandwidth memory chips is expected to persist beyond calendar year 2026.
AppLovin's Q4 performance showcases the strength of its AI models, despite market sentiment concerns. Cisco's AI infrastructure orders indicate a growing demand for AI-related hardware. McDonald's success is attributed to its focus on value and successful marketing promotions. Gilead's HIV drug sales, particularly Yeztugo, drive its earnings beat. Micron's early HBM4 shipments position it to capitalize on the high demand for memory chips.
These earnings reports reflect a mix of factors, including technological advancements (AI, memory chips), strategic focus (value offerings), and market dynamics (HIV drug demand).
What were the main drivers of AppLovin's Q4 success?
The growth in its own AI models.
Why is Cisco's AI infrastructure important?
It indicates a growing demand for AI-related hardware and Cisco's position in this market.
What contributed to McDonald's earnings beat?
Its focus on value and successful marketing promotions.
Which drug is driving Gilead's earnings?
Sales of its HIV drugs, particularly Yeztugo.
What is HBM4?
The newest edition of high-bandwidth memory chips, with Micron starting shipments ahead of schedule.
This earnings roundup provides a snapshot of how different companies are performing across various sectors. Key takeaways include the importance of AI in driving growth (AppLovin, Cisco), the effectiveness of value-driven strategies (McDonald's), and the impact of new products (Gilead, Micron). Investors and industry observers can use this information to better understand current market trends and company performance.
What are your thoughts on these Q4 earnings results? Do you think these trends will continue? Share this article with others who need to stay ahead of this trend!
Zscaler (ZS) announced its Q3 2026 earnings on May 26, revealing strong results but mixed guidance that led to a significant market reaction...
As Nvidia prepares to release its Q1 earnings report on May 20, 2026, prediction markets and analysts are buzzing with expectations. This ar...
Texas Instruments (TXN) reported its Q1 2026 earnings, showcasing revenue growth and strong shareholder returns. This article delves into th...
Morgan Stanley (MS) has announced its Q1 2026 earnings, surpassing analyst expectations due to a significant boost in trading revenue. The f...
⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer